Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001167557-26-000255·AQR CAPITAL MANAGEMENT LLC
Schedule 13G ownership disclosure
Sarepta Therapeutics Inc
Common Stock, $0.0001 par value per share · CUSIP: 803607100
Event date: 2026-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- AQR Capital Management, LLC
Shares: 1,386,343 · Class: 1.31%
- AQR Capital Management Holdings, LLC
Shares: 1,386,343 · Class: 1.31%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001167557-26-000255
- Form type
- SCHEDULE 13G/A
- Filer
- AQR CAPITAL MANAGEMENT LLC
- CIK
- CIK 1167557
- Filed
- Nov 13, 2026
- Reporting period
- Sep 30, 2026
- Description
- Schedule 13G beneficial ownership